<< Back to News

Immediate Action Required to Protect Community Cancer Care

During recent negotiations of the federal budget and the national debt, several proposals to cut Medicare and Medicaid have been discussed including a proposal to reduce reimbursement for physician administered Medicare Part B drugs from the current ASP +6% to ASP +4%. Such a reduction in drug reimbursement would jeopardize cancer care in the community setting. 

In response to the proposed ASP cut, ACCC, ASCO, Amerisource Bergen, Community Oncology Alliance (COA), the Healthcare Distribution Management Association, McKesson, the National Coalition for Cancer Survivorship, the National Patient Advocate Foundation, US Oncology Network and UPMC Cancer Centers signed a joint letter to the White House and national debt ceiling negotiators opposing the cuts to cancer drugs and biologicals under the Medicare Part B program. Click Here to read the letter.  

If you haven’t already done so please out to your Representatives, Senators and the President urging them to oppose this reduction to cancer care. You can easily contact your legislators through ASCO's ACT Network.  The link provides contact information, a summary of the proposed ASP reduction and talking points when speaking to your elected officials. It is important to act as soon as possible.